Twinning is one of the actions from the “Spreading Excellence and Widening Participation” call of Horizon 2020 programme. Its main aim is to address networking gaps and deficiencies between the research institutions of the low performing Member States and internationally-leading counterparts at EU level. Twinning will strengthen a defined field of research in a particular knowledge institution through linking this institution with at least two research institutions in other Member States.
ReTuBi - REsearch in TUmour BIology
Cancer is a worldwide leading cause of death and is a major public health issue. It has also an impact in economic growth, through premature death and disability arising from cancer. Moreover, it has been estimated that 1 in 2 people in the EU will get cancer in their lifetime.
The Instituto de Medicina Molecular (iMM, Portugal) aims to fight this destructive disease by reinforcing its capacity for outstanding pre-clinical and translation research. The overall goal is to strengthen iMM in REsearch in TUmour BIology through the establishment of a network of interactions between iMM, Institut Curie (France) and the Deutsches Krebsforschungszentrum (DKFZ, Germany).
- Improve the quality and impact of pre-clinical research in tumour biology at iMM
- Implement and develop novel technology at iMM, Institut Curie and DFKZ crucial to tackle current and future challenges in tumour biology
- Stimulate a long-term impact in innovation at iMM, Institut Curie and DFKZ by fostering research excellence and technological development
- Enhance iMM researchers’ ability to integrate networks of excellence within Europe
- Promote awareness of the societal impact of iMM’s research in the cancer field, with special focus in oncological patients and respective families as well as the medical community at the Lisbon Academic Medical Centre
How does it work?
ReTuBi consortium is composed by research and support units from iMM and two leading research institutes, the Institut Curie in France (the largest European cancer research centre) and the DKFZ – Deutsches Krebsforschungszentrum (the largest cancer research institute in Germany).
The ReTuBi Management Team is headed by the Coordinator of the project, Edgar Gomes (iMM) who is supported by a senior technician and an administrative manager in all administrative, technical and financial issues.
An Advisory Board will closely monitor the progress of the project, providing independent expert opinion, and formally discuss with the Steering Committee:
- Giorgio Scita | IFOM Cancer Research Institute, Italy
- Michael Way | The Francis Crick Institute, UK
- Massimiliano Mazzone | VIB Vesalius Research Centre, Belgium
ReTuBi expects an increase of 30% in multiple indicators until 2020 including the number of publication in top 10% peer-reviewed journals, number of citations, and number of communications in scientific meetings. It will potentiate iMM scientific and innovation capacity and will increase international visibility and collaborations. ReTuBi will also have an impact in the entire iMM community and Lisbon area, through organisation of open scientific meetings, summer schools and workshops.
Short-term staff exchanges will establish interactions between different groups of iMM, Curie and DKFZ. The majority of the staff exchanges are expected to involve the travelling of a staff element (e.g. PhD student, Post-doc, Group Leader) from one partner lab to another partner lab from the ReTuBi consortium.
Two workshops will be organised to young researchers, PhD students, post-docs and medical students, to benefit the scientific excellence of the regional and national community, which will include technology-driven activities (e.g., microscopy) as well as soft skills activities (e.g. scientific writing, presentation skills).
Expert visits and Summer Schools
Organisation of summer-schools and expert visits to iMM will deliver a long-term raise in the quality of the research output from the iMM research community, with a special focus on the PhD and post-doc communities. Expert visits will be associated to informal social gathering in public libraries or coffee shops for science dissemination with special focus on cancer.
Three project meetings will be organised throughout RetuBi: kick-off meeting, an interim project meeting and the final project meeting. These meetings will have a scientific symposia open to the community as well as an internal meeting for the evaluation of the implementation of the project.
Dissemination and outreach
ReTuBi consortium will promote open days and public interaction where patients and relatives can talk to scientists about ongoing research programmes.